No Data
No Data
Qiagen Obtains US FDA Clearance for Respiratory Syndromic Testing Panel
Qiagen (QIA.F) on Monday said the US Food and Drug Administration authorized its QIAstat-Dx respiratory syndromic testing panel for clinical use. The molecular testing company's QIAstat-Dx Respiratory
Express News | NYSE Order Imbalance 92847.0 Shares on Buy Side
Express News | NYSE Order Imbalance 58834.0 Shares on Buy Side
QIAGEN Partners With FBI to Develop Digital PCR Assay for QIAcuity for Use in Forensics
Collaboration aims to create novel digital PCR assay to improve successful results in DNA analysis from human samples for use in forensics and human identification // DNA quantification enables law en
Express News | NYSE Order Imbalance 64100.0 Shares on Sell Side
Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
Earnings reports and a dovish stance from the Federal Reserve lifted stocks last week. Major indices reacted positively, particularly to earnings from high-profile companies that hold significant weig